Key clinical trials of contezolid (sponsored by MicuRx Pharmaceuticals, Inc.)

Drug(s)	Indication	Phase	Status	Location(s)	Identifier
Contezolid	Bacterial infections, skin and soft tissue infections	III	Planning	Multinational
Contezolid	Acute bacterial skin and skin structure infections	III	Planning	USA
Contezolid, linezolid	Complicated skin and soft tissue infections	III	Completed	China
Contezolid, linezolid	Acute bacterial skin and skin structure infections	II	Completed	USA	NCT02269319
Contezolid, linezolid	Complicated skin and soft tissue infections	II	Completed	China